BioSpace News Archive

The Lung Cancer Research Foundation (LCRF) and ALK Positive Inc. (ALK Positive) announce a research partnership to fund ALK-positive related lung cancer projects.

Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) posted briefing documents for the March 30, 2022 Peripheral and Central Nervous System Drugs Advisory Committee (PCNSDAC) meeting to review the Company’s New Drug Application (NDA) for AMX0035 (sodium phenylbutyrate [PB] and taurursodiol.

Funding Will Reach Under-Resourced Communities Most Impacted by the HIV Epidemic and COVID-19 Pandemic Gilead Sciences, Inc., announced $24 million in grants to help reduce health disparities, improve access to quality healthcare, advance medical education and support local communities most impacted by the HIV epidemic and COVID-19 pandemic.

Sino Biological, Inc.(“Sino Biological” or the “Company”), a biotechnology company listed on the Shenzhen stock exchange subsidiary ChiNext (SZSE: 301047), which provides biological research reagents and related technical contract research services, is pleased to announce a CRO services partnership with Ainnocence, Inc. of San Jose, California.

InFlectis BioScience received Orphan-Drug Designation from the U.S. Food and Drug Administration (FDA) for its investigational treatment for Amyotrophic Lateral Sclerosis (ALS), IFB-088.

Increasing adoption of hybrid data storage solutions, rising geriatric population, rapid technological advancements, and high adoption of automation in the healthcare sector are some key factors expected to drive global market growth.

Increasing investments in research and development activities, rapid advancements in next-generation sequencing techniques, and growing awareness about exome sequencing technology are some key factors expected to drive global market growth.

The global pharma & healthcare market report points out the key trends and developments taking place in this business space in the ongoing COVID-19 times.

The global pharma & healthcare market report points out the key trends and developments taking place in this business space in the ongoing COVID-19 times.

The industry analysis report is considered a valuable source of information about the global Embolization Particles industry and lays stress on the future market scope, emerging industry trends, industry statistics, and market growth potential during the forecast years.